How I approach new onset thrombocytopenia

References

• Arnold DM, Lim W. A rational approach to the diagnosis and management of thrombocytopenia in the hospitalized patient. Semin Hematol 2011;48(4):251–258. doi:10.1053/j.seminhematol.2011.08.002
   PubMed Web of Science ®Google Scholar
• Bain BJ. Blood cells: a practical guide. 5th ed. West Sussex: John Wiley & Sons; 2015. p253–p255 p.
   Google Scholar
• Page LK, Psaila B, Provan D, Michael Hamilton J, Jenkins JM, Elish AS, Lesser ML, Bussel JB. The immune thrombocytopenic purpura (ITP) bleeding score: assessment of bleeding in patients with ITP. Br J Haematol 2007;138(2):245–248. doi:10.1111/j.1365-2141.2007.06635.x
   PubMed Web of Science ®Google Scholar
• Rodeghiero F, Michel M, Gernsheimer T, Ruggeri M, Blanchette V, Bussel JB, Cines DB, Cooper N, Godeau B, Greinacher A, et al. Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group. Blood 2013;121(14):2596–2606. doi:10.1182/blood-2012-07-442392
   PubMed Web of Science ®Google Scholar
• Crosby WH. Wet purpura, dry purpura. JAMA 1975;232(7):744–745.
   PubMed Web of Science ®Google Scholar
• Neunert C. Individualising treatment for immune thrombocytopenia: predicting bleeding risk. Semin Hematol 2013;50(s1):55–57. doi:10.1053/j.seminhematol.2013.03.009
   Google Scholar
• Schoonen WM, Kucera G, Coalson J, Li L, Rutstein M, Mowat F, Fryzek J, Kaye JA. Epidemiology of immune thrombocytopenic purpura in the General Practice Research Database. Br J Haematol 2009;145(2):235–244. doi:10.1111/j.1365-2141.2009.07615.x
   PubMed Web of Science ®Google Scholar
• Arnold DM, Nazy I, Clare R, Jaffer AM, Aubie B, Li N, Kelton JG. Misdiagnosis of primary immune thrombocytopenia and frequency of bleeding: lessons from the McMaster ITP Registry. Blood Adv 2017;1(25):2414–2420. doi:10.1182/bloodadvances.2017010942
   PubMed Web of Science ®Google Scholar
• Bareau B, Rey J, Hamidou M, Donadieu J, Morcet J, Reman O, Schleinitz N, Tournilhac O, Roussel M, Fest T, et al. Analysis of a French cohort of patients with large granular lymphocyte leukaemia: a report on 229 cases. Haematologica 2010;95(9):1534–1541. doi:10.3324/haematol.2009.018481
   PubMed Web of Science ®Google Scholar
• Zent CS, Ding W, Schwager SM, Reinalda MS, Hoyer JD, Jelinek DF, Tschumper RC, Bowen DA, Call TG, Shanafelt TD, et al. The prognostic significance of cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL). Br J Haematol 2008;141:615–621. doi:10.1111/j.1365-2141.2008.07086.x
   PubMed Web of Science ®Google Scholar
• Hauswirth AW, Skrabs C, Schutzinger C, Raderer M, Chott A, Valent P, Lechner K, Jäger U. Autoimmune thrombocytopenia in Non-Hodgkin’s lymphomas. Haematologica 2008;93(3):447–450. doi:10.3324/haematol.11934
   PubMed Web of Science ®Google Scholar
• Fujimara Y, Matsumoto M, Isonishi A, Yagi H, Kokame K, Soejima K, Murata M, Miyata T. Natural history of Upshaw-Schulman syndrome based on ADAMTS13 gene analysis in Japan. J Thromb Haemost 2011;S1:283–301. doi:10.1111/j.1538-7836.2011.04341.x
   Google Scholar
• Binder V, Albert MH, Kabus M, Bertone M, Meindl A, Belohradsky BH. The genotype of the original Wiskott phenotype. N Engl J Med 2006;355(17):1790–1793. doi:10.1056/NEJMoa062520
   PubMed Web of Science ®Google Scholar
• Stasi R, Sarpatwari A, Segal JB, Osborn J, Evangelista ML, Cooper N, Provan D, Newland A, Amadori S, Bussel JB. Effects of eradication of Helicobacter pylori infection in patients with immune thrombocytopenic purpura: a systematic review. Blood 2009;113(6):1231–1240. doi:10.1182/blood-2008-07-167155
   PubMed Web of Science ®Google Scholar
• Cines DB, Liebman H, Stasi R. Pathobiology of secondary immune thrombocytopenia. Semin Hematol 2009;46(1 Suppl 2):S2–14. doi:10.1053/j.seminhematol.2008.12.005
   PubMed Web of Science ®Google Scholar
• Mitchell O, Feldman DM, Diakow M, Sigal SH. The pathophysiology of thrombocytopenia in chronic liver disease. Hepat Med 2016;8:39–50. doi:10.2147/HMER.S74612
   PubMed Web of Science ®Google Scholar
• George JN, Aster RH. Drug-induced thrombocytopenia: pathogenesis, evaluation, and management. Hematology Am Soc Hematol Educ Program 2009;2009:153–158. doi:10.1182/asheducation-2009.1.153
   Google Scholar
• Arnold DM, Nazi I, Warkentin TE, Smith JW, Toltl LJ, George JN, Kelton JG. Approach to the diagnosis and management of drug-induced immune thrombocytopenia. Transf Med Rev 2013;27(3):137–145. doi:10.1016/j.tmrv.2013.05.005
   PubMed Web of Science ®Google Scholar
• Arnold DM, Kukaswadia S, Nazi I, Esmail A, Dewar L, Smith JW, Warkentin TE, Kelton JG. A systematic evaluation of laboratory testing for drug-induced immune thrombocytopenia. J Thromb Haemost 2013;11(1):169–176. doi:10.1111/jth.12052
   PubMed Web of Science ®Google Scholar
• Lo GK, Juhl D, Warkentin TE, Sigouin CS, Eichler P, Greinacher A. Evaluation of pretest clinical score (4 T’s) for the diagnosis of heparin-induced thrombocytopenia in two clinical settings. J Thromb Haemost 2006;4(4):759–765. doi:10.1111/j.1538-7836.2006.01787.x
   PubMed Web of Science ®Google Scholar
• Merino A. Blood film findings in severe babesiosis. Br J Haematol 2016;172(6):839. doi:10.1111/bjh.13845
   PubMedGoogle Scholar
• Vannier E, Krause PJ. Human babesiosis. N Engl J Med 2012;366(25):2397–2407. doi:10.1056/NEJMra1202018
   PubMed Web of Science ®Google Scholar
• Lindenbaum J. Hematologic complications of alcohol abuse. Semin Liver Dis 1987;7(3):169–181. doi:10.1055/s-2008-1040574
   PubMed Web of Science ®Google Scholar
• Wu A, Chanarin I, Levi AJ. Macrocytosis of chronic alcoholism. Lancet 1974;1(7862):829–831. doi:10.1016/s0140-6736(74)90482-6
   PubMed Web of Science ®Google Scholar
• Althaus K, Greinacher A. MYH-9 related platelet disorders: strategies for management and diagnosis. Transfus Med Hemother 2010;37(5):260–267. doi:10.1159/000320335
   PubMed Web of Science ®Google Scholar
• Schlegelberger B, Heller PG. RUNX1 deficiency (familial platelet disorder with predisposition to myeloid leukaemia, FPDMM). Semin Hematol 2017;54(2):75–80. doi:10.1053/j.seminhematol.2017.04.006
   PubMed Web of Science ®Google Scholar
• Zandecki M, Genevieve F, Gerard J, Godon A. Spurious counts and spurious results on haematology analysers: a review. Part I: platelets. Int J Lab Hematol 2007;29(1):4–20.
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Tanaka Y, Gondo K, Maruki Y, Kondo T, Asai S, Matsushita H, Miyachi H. Performance evaluation of platelet counting by novel fluorescent dye staining in the XN-series automated hematology analyzers. J Clin Lab Anal 2014;28(5):341–348. doi:10.1002/jcla.21691
   PubMed Web of Science ®Google Scholar
• Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010;115(2):168–186. doi:10.1182/blood-2009-06-225565
   PubMed Web of Science ®Google Scholar
• Brighton TA, Evans S, Castaldi PA, Chesterman CN, Chong BH. Prospective evaluation of the clinical usefulness of an antigen-specific assay (MAIPA) in idiopathic thrombocytopenic purpura and other immune thrombocytopenias. Blood 1996;88(1):194–201.
   PubMed Web of Science ®Google Scholar
• McMillan R, Wang L, Tani P. Prospective evaluation of the immunobead assay for the diagnosis of adult chronic immune thrombocytopenic purpura (ITP). J Thromb Haemost 2003;1(3):485–491.
   PubMed Web of Science ®Google Scholar
• Rabbolini DJ, Chun Y, Latimer M, Kunishima S, Fixter K, Valecha B, Tan P, Chew LP, Kile BT, Burt R, et al. Diagnosis and treatment of MYH9-RD in an Australiasian cohort with thrombocytopenia. Platelets 2018;29(8):1–8. doi:10.1080/09537104.2017.1417660
   PubMed Web of Science ®Google Scholar
• Bowles KM, Cooke LJ, Richards EM, Baglin TP. Platelet size has diagnostic predictive value in patients with thrombocytopenia. Clin Lab Haematol 2005;27(6):370–373. doi:10.1111/j.1365-2257.2005.00726.x
   PubMedGoogle Scholar
• Ntaios G, Papdopoulos A, Chatzinikolaou A, Saouli Z, Karalazou P, Kaiafa G, Girtovitis F, Kontoninas Z, Savopoulos C, Hatzitolios A, et al. Increased values of mean platelet volume and platelet size deviation width may provide a safe positive diagnosis of idiopathic thrombocytopenic purpura. Acta Haematol 2008;119(3):173–177. doi:10.1159/000135658
   PubMed Web of Science ®Google Scholar
• Numbenjapon T, Mahapo N, Pornvipavee R, Sriswasdi C, Mongkonsritragoon W, Leelasiri A, Prayoonwiwat W. A prospective evaluation of normal mean platelet volume in discriminating hypderdestructive thrombocytopenia from hypoproductive thrombocytopenia. Int J Lab Hematol 2008;30(5):408–414. doi:10.1111/j.1751-553X.2007.00969.x
   PubMed Web of Science ®Google Scholar
• McDonnell A, Bride K, Lim D, Paessler M, Witmer CM, Lambert MP. Utility of the immature platelet fraction in pediatric immune thrombocytopenia: differentiating from bone marrow failure and predicting bleeding risk. Pediatr Blood Cancer 2018;65(2):ePub. doi:10.1002/pbc.v65.2
   Web of Science ®Google Scholar
• Cybulska A, Meintker L, Ringwald J, Krause SW. Measurements of immature platelets with haematology analysers are of limited value to separate immune thrombocytopenia from bone marrow failure. Br J Haematol 2017;177(4):612–619. doi:10.1111/bjh.14628
   PubMed Web of Science ®Google Scholar
• Miyazaki K, Koike Y, Kunishima S, Ishii R, Danbara M, Horie R, Yatomi Y, Higashihara M. Immature platelet fraction measurement is influenced by platelet size and is a useful parameter for discrimination of macrothrombocytopenia. Hematology 2015;20(10):587–592. doi:10.1179/1607845415Y.0000000021
   PubMed Web of Science ®Google Scholar
• Lacey JV, Penner JA. Management of idiopathic thrombocytopenic purpura in the adult. Semin Thromb Hemost 1977;3(3):160–174.
   PubMed Web of Science ®Google Scholar
• Choen YC, Djulbegovic B, Shamai-Lubovitz O, Mozes B. The bleeding risk and natural history of idiopathic thrombocytopenic purpura in patients with persistently low platelet counts. Arch Intern Med 2000;160(11):1630–1638.
   PubMedGoogle Scholar